Loading insider details...
Latest Form 4 (Sep 8, 2026): Sale of 900 DYN shares, $21.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 900 | $21.9K |
| Aug 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 226 | $5.9K |
| Jun 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 145 | $2.7K |
| May 14, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 228 | $4.2K |
| Mar 6, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 148 | $2.2K |
| Feb 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 60,000 | n/a |
| Dec 5, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 144 | $3.0K |
| Sep 8, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 894 | $11.9K |
| Jul 18, 2025 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 51,255 | n/a |
| Jun 6, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 146 | $1.9K |